Fred C. Jensen

5.8k total citations
92 papers, 4.9k citations indexed

About

Fred C. Jensen is a scholar working on Immunology, Virology and Molecular Biology. According to data from OpenAlex, Fred C. Jensen has authored 92 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 31 papers in Virology and 29 papers in Molecular Biology. Recurrent topics in Fred C. Jensen's work include HIV Research and Treatment (31 papers), Virus-based gene therapy research (19 papers) and Immune Cell Function and Interaction (18 papers). Fred C. Jensen is often cited by papers focused on HIV Research and Treatment (31 papers), Virus-based gene therapy research (19 papers) and Immune Cell Function and Interaction (18 papers). Fred C. Jensen collaborates with scholars based in United States, Canada and Australia. Fred C. Jensen's co-authors include Hilary Koprowski, Anthony J. Girardi, Roland C. Aloia, Richard A. Lerner, John H. Elder, Michael B. A. Oldstone, Neil R. Cooper, Hua Tian, Raymond M. Welsh and James W. Gautsch and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Fred C. Jensen

91 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred C. Jensen United States 32 1.7k 1.5k 1.3k 1.2k 996 92 4.9k
Murray B. Gardner United States 38 1.8k 1.0× 1.8k 1.2× 2.5k 2.0× 1.4k 1.1× 1.7k 1.7× 135 6.2k
Ian A. Ramshaw Australia 41 1.4k 0.8× 3.4k 2.3× 1.3k 1.0× 926 0.8× 1.7k 1.7× 125 6.3k
Steven Kessler United States 23 2.6k 1.5× 1.9k 1.3× 507 0.4× 1.4k 1.1× 668 0.7× 50 5.7k
Amos Panet Israel 42 2.9k 1.7× 1.3k 0.9× 936 0.7× 1.3k 1.0× 1.4k 1.4× 175 5.7k
Angela Granelli‐Piperno United States 39 1.6k 0.9× 3.8k 2.6× 1.4k 1.1× 461 0.4× 887 0.9× 67 7.0k
Tristram G. Parslow United States 43 4.8k 2.7× 2.4k 1.6× 1.6k 1.3× 1.2k 1.0× 980 1.0× 71 8.3k
Volker Erfle Germany 40 2.4k 1.4× 1.9k 1.3× 2.2k 1.7× 939 0.8× 1.3k 1.3× 175 5.7k
Sisir K. Chattopadhyay United States 34 1.4k 0.8× 1.5k 1.0× 1.2k 0.9× 1.4k 1.1× 727 0.7× 86 4.2k
Ronald C. Kennedy United States 39 1.5k 0.8× 1.8k 1.2× 1.1k 0.8× 445 0.4× 862 0.9× 161 4.7k
Jeffrey A. Frelinger United States 49 2.1k 1.2× 4.6k 3.1× 660 0.5× 1.0k 0.8× 1.2k 1.2× 214 8.0k

Countries citing papers authored by Fred C. Jensen

Since Specialization
Citations

This map shows the geographic impact of Fred C. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred C. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred C. Jensen more than expected).

Fields of papers citing papers by Fred C. Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred C. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred C. Jensen. The network helps show where Fred C. Jensen may publish in the future.

Co-authorship network of co-authors of Fred C. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Fred C. Jensen. A scholar is included among the top collaborators of Fred C. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred C. Jensen. Fred C. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moss, Ronald B., et al.. (2000). HIV-Specific CD4 + and CD8 + Immune Responses Are Generated with a gp120-Depleted, Whole-Killed HIV-1 Immunogen with CpG Immunostimulatory Sequences of DNA. Journal of Interferon & Cytokine Research. 20(12). 1131–1137. 15 indexed citations
2.
Moss, Ronald B., Fred C. Jensen, & Dennis J. Carlo. (2000). Insights into HIV-Specific Immune Function: Implications for Therapy and Prevention in the New Millennium. Clinical Immunology. 95(2). 79–84. 4 indexed citations
3.
4.
Churdboonchart, Vina, Ronald B. Moss, Worachart Sirawaraporn, et al.. (1998). Effect of HIV-specific immune-based therapy in subjects infected with HIV-1 subtype E in Thailand. AIDS. 12(12). 1521–1527. 12 indexed citations
5.
Lanza, Paola, Ronald B. Moss, Wieslawa Giermakowska, et al.. (1998). Whole-killed gp120-depleted HIV-1 antigen in a murine model for prophylactic vaccination. Vaccine. 16(7). 727–731. 4 indexed citations
6.
7.
Dube, Syamalima, et al.. (1997). HIV Type 1 Isolate Z321, the Strain Used to Make a Therapeutic HIV Type 1 Immunogen, Is Intersubtype Recombinant. AIDS Research and Human Retroviruses. 13(4). 357–361. 50 indexed citations
8.
Ferré, F., Ronald B. Moss, Anne E. Daigle, et al.. (1996). Combination Therapies Against HIV-1 Infection: Exploring the Concept of Combining Antiretroviral Drug Treatments with HIV-1 Immune-Based Therapies in Asymptomatic Individuals. . .. AIDS Patient Care and STDs. 10(6). 357–361. 3 indexed citations
9.
Levine, Alexandra M., Susan Groshen, Dennis J. Carlo, et al.. (1996). Initial Studies on Active Immunization of HIV-Infected Subjects Using a gp120-Depleted HIV-1 Immunogen: Long-Term Follow-Up. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 11(4). 351–364. 46 indexed citations
10.
Trauger, Richard, F. Ferré, Anne E. Daigle, et al.. (1994). Effect of Immunization with Inactivated gp120-Depleted Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen on HIV-1 Immunity, Viral DNA, and Percentage of CD4 Cells. The Journal of Infectious Diseases. 169(6). 1256–1264. 60 indexed citations
11.
12.
Ferré, F., D E Lewis, Mark R. Wallace, et al.. (1992). Quantitation of HIV Viral Burden by PCR in HIV Seropositive Navy Personnel Representing Walter Reed Stages 1 to 6. AIDS Research and Human Retroviruses. 8(2). 269–275. 30 indexed citations
13.
Gordon, Larry M., Fred C. Jensen, Cyril C. Curtain, Patrick W. Mobley, & Roland C. Aloia. (1988). Thermotropic lipid phase separation in the human immunodeficiency virus. Biochimica et Biophysica Acta (BBA) - Biomembranes. 943(2). 331–342. 18 indexed citations
14.
Burd, John F., et al.. (1984). Production and Characterization of Monoclonal Antibody to Gentamicin. Hybridoma. 3(2). 187–193. 1 indexed citations
15.
Jensen, Fred C., et al.. (1982). Mono clonal antibodies in substrate labeled fluorescent immunoassays for gentamicin and netilmicin in human serum. Clinical Chemistry. 28(7). 1663. 3 indexed citations
16.
Izui, Shozo, G Fernandes, I. Hara, et al.. (1981). Low-calorie diet selectively reduces expression of retroviral envelope glycoprotein gp70 in sera of NZB x NZW F1 hybrid mice.. The Journal of Experimental Medicine. 154(4). 1116–1124. 42 indexed citations
17.
Jensen, Fred C., et al.. (1976). Effects of Complete and Incomplete Girdles on `Thompson Seedless' and `Ribier' Table Grapes. American Journal of Enology and Viticulture. 27(2). 65–67. 3 indexed citations
18.
Olding, Lars B., Fred C. Jensen, & Michael B. A. Oldstone. (1975). Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction.. The Journal of Experimental Medicine. 141(3). 561–572. 184 indexed citations
19.
Jensen, Fred C., Fred Swanson, W. Frank Peacock, & George Leavitt. (1975). The Effect of Width of Cane and Trunk Girdles on Berry Weight and Soluble Solids in Table 'Thompson Seedless' Vineyards. American Journal of Enology and Viticulture. 26(2). 90–91. 3 indexed citations
20.
Croker, Byron P., Bert C. Del Villano, Fred C. Jensen, Richard A. Lerner, & Frank J. Dixon. (1974). IMMUNOPATHOGENICITY AND ONCOGENICITY OF MURINE LEUKEMIA VIRUSES. The Journal of Experimental Medicine. 140(4). 1028–1048. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Murray B. Gardner Breakdown of academic impact, for papers by Ian A. Ramshaw Breakdown of academic impact, for papers by Steven Kessler Breakdown of academic impact, for papers by Amos Panet Breakdown of academic impact, for papers by Angela Granelli‐Piperno Breakdown of academic impact, for papers by Tristram G. Parslow Breakdown of academic impact, for papers by Volker Erfle Breakdown of academic impact, for papers by Sisir K. Chattopadhyay Breakdown of academic impact, for papers by Ronald C. Kennedy Breakdown of academic impact, for papers by Jeffrey A. Frelinger
Rankless by CCL
2026